ACADIA Pharmaceuticals focuses on the use of innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders. ACADIA has four product candidates in clinical development, including a potential first-in-class treatment for Parkinson’s disease psychosis; a candidate for chronic pain; a product candidate for glaucoma; and AM-831 for schizophrenia. For more information visit the company’s Web site at www.acadia-pharm.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: